ACAD
34.3
-0.68
-1.94%
AEMD
4.96
-0.15
-2.94%
APRI
0.342
-0.008
-2.3163%
ARNA
1.73
-0.01
-0.57%
ATEC
8.21
-0.42
-4.87%
CNAT
2.1
-0.01
-0.47%
CRXM
0.24
-0.03
-10.70%
CYTX
2.04
-0.08
-3.77%
DXCM
93.16
-0.75
-0.80%
GNMK
11.56
-0.14
-1.20%
HALO
11.98
-0.11
-0.91%
ILMN
178.47
-0.86
-0.48%
INNV
0.29
+0.01
+3.5357%
INO
9.44
-0.06
-0.63%
ISCO
1.84
-0.06
-3.16%
ISIS
57.56
0.00
0.00%
LGND
113.09
-2.69
-2.32%
LPTN
3.83
-0.06
-1.54%
MBVX
4.16
-0.56
-11.86%
MEIP
1.71
+0.02
+1.18%
MNOV
7.47
+0.37
+5.21%
MRTX
6.2
+0.32
+5.44%
MSTX
0.123
-0.004
-3.454%
NBIX
53.25
-0.69
-1.28%
NUVA
66.15
-0.62
-0.93%
ONCS
1.77
-0.01
-0.56%
ONVO
3.91
-0.06
-1.51%
OREX
3.24
-0.22
-6.36%
OTIC
17.13
-0.52
-2.95%
QDEL
22.17
-0.54
-2.38%
RCPT
231.96
0.00
0.00%
RGLS
3.42
-0.03
-0.87%
RMD
63.59
+0.34
+0.54%
SPHS
3.22
+0.26
+8.78%
SRNE
7.67
-0.1
-1.29%
TROV
4.63
-0.16
-3.34%
VICL
3.19
-0.06
-1.85%
VOLC
18
0.00
0.00%
ZGNX
10.35
-0.1
-0.96%
ACAD
34.3
-0.68
-1.94%
AEMD
4.96
-0.15
-2.94%
APRI
0.342
-0.008
-2.3163%
ARNA
1.73
-0.01
-0.57%
ATEC
8.21
-0.42
-4.87%
CNAT
2.1
-0.01
-0.47%
CRXM
0.24
-0.03
-10.70%
CYTX
2.04
-0.08
-3.77%
DXCM
93.16
-0.75
-0.80%
GNMK
11.56
-0.14
-1.20%
HALO
11.98
-0.11
-0.91%
ILMN
178.47
-0.86
-0.48%
INNV
0.29
+0.01
+3.5357%
INO
9.44
-0.06
-0.63%
ISCO
1.84
-0.06
-3.16%
ISIS
57.56
0.00
0.00%
LGND
113.09
-2.69
-2.32%
LPTN
3.83
-0.06
-1.54%
MBVX
4.16
-0.56
-11.86%
MEIP
1.71
+0.02
+1.18%
MNOV
7.47
+0.37
+5.21%
MRTX
6.2
+0.32
+5.44%
MSTX
0.123
-0.004
-3.454%
NBIX
53.25
-0.69
-1.28%
NUVA
66.15
-0.62
-0.93%
ONCS
1.77
-0.01
-0.56%
ONVO
3.91
-0.06
-1.51%
OREX
3.24
-0.22
-6.36%
OTIC
17.13
-0.52
-2.95%
QDEL
22.17
-0.54
-2.38%
RCPT
231.96
0.00
0.00%
RGLS
3.42
-0.03
-0.87%
RMD
63.59
+0.34
+0.54%
SPHS
3.22
+0.26
+8.78%
SRNE
7.67
-0.1
-1.29%
TROV
4.63
-0.16
-3.34%
VICL
3.19
-0.06
-1.85%
VOLC
18
0.00
0.00%
ZGNX
10.35
-0.1
-0.96%
Home » Events

SDBDG BioTalk: Nuvasive

Submitted by on December 29, 2008 – 9:17 am

San Diego Biotechnology Discussion Group’s January BioTalk: Nuvasive, January 28, 2009, 5:30-8:00 p.m., Sorrento Summit (adjacent to Nuvasive HQ)

Leave a comment!

Add your comment below, or trackback from your own site. You can also Comments Feed via RSS.

Be nice. Keep it clean. Stay on topic. No spam.

You can use these tags:

<a href="" title="" rel=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong> 

This is a Gravatar-enabled weblog. To get your own globally-recognized-avatar, please register at Gravatar.

Please prove you\'re human, solve this: *
Time limit is exhausted. Please reload CAPTCHA.